These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 10219074

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure.
    Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA.
    N Engl J Med; 1999 Apr 29; 340(17):1321-8. PubMed ID: 10219067
    [Abstract] [Full Text] [Related]

  • 3. Calcium channel blockers: effects on progressive renal disease.
    Zucchelli P, Zuccalà A, Gaggi R.
    Am J Kidney Dis; 1991 May 29; 17(5 Suppl 1):94-7. PubMed ID: 2024684
    [No Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.
    Zucchelli P, Zuccalà A, Gaggi R.
    Nephrol Dial Transplant; 1995 Oct 29; 10 Suppl 9():46-51. PubMed ID: 8643208
    [No Abstract] [Full Text] [Related]

  • 5. Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.
    Linas S.
    Am J Kidney Dis; 1990 Oct 29; 16(4 Suppl 1):15-9. PubMed ID: 2220796
    [Abstract] [Full Text] [Related]

  • 6. [Hemodialysis-associated hypertension; pathophysiology and therapy].
    Suzuki H.
    Nihon Rinsho; 2004 Jun 29; 62 Suppl 6():220-4. PubMed ID: 15250299
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of hypertension in chronic renal insufficiency.
    Locatelli F, Manzoni C, Marcelli D.
    J Nephrol; 1997 Jun 29; 10(4):220-3. PubMed ID: 9377731
    [Abstract] [Full Text] [Related]

  • 8. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M, Rodrigue ME, Agharazii M, Larivière R.
    Am J Hypertens; 2006 Dec 29; 19(12):1286-92. PubMed ID: 17161776
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Protecting the kidney in hypertension.
    Weinberg MS, Cottiero RA, Yoburn DC.
    R I Med; 1993 May 29; 76(5):225-8. PubMed ID: 8518496
    [No Abstract] [Full Text] [Related]

  • 12. Sympathetic and renin-angiotensin systems contribute to increased blood pressure in sucrose-fed rats.
    Freitas RR, Lopes KL, Carillo BA, Bergamaschi CT, Carmona AK, Casarini DE, Furukawa L, Heimann JC, Campos RR, Dolnikoff MS.
    Am J Hypertens; 2007 Jun 29; 20(6):692-8. PubMed ID: 17531930
    [Abstract] [Full Text] [Related]

  • 13. Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.
    Lenz T, August P.
    Wien Klin Wochenschr; 1990 May 25; 102(11):315-9. PubMed ID: 2195780
    [Abstract] [Full Text] [Related]

  • 14. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M, Pressel S, Davis BR, Nwachuku C, Wright JT, Whelton PK, Barzilay J, Batuman V, Eckfeldt JH, Farber M, Henriquez M, Kopyt N, Louis GT, Saklayen M, Stanford C, Walworth C, Ward H, Wiegmann T.
    Arch Intern Med; 2005 Apr 25; 165(8):936-46. PubMed ID: 15851647
    [Abstract] [Full Text] [Related]

  • 15. [ACE-inhibitors in renal protection].
    Barna I.
    Orv Hetil; 2006 Jun 04; 147(22):1019-23. PubMed ID: 16913091
    [Abstract] [Full Text] [Related]

  • 16. [Chronic renal failure--taming the sympathetic nervous system! New approach to delaying progression].
    Rump LC, Oberhauser V.
    MMW Fortschr Med; 1999 Nov 18; 141(46):39-41. PubMed ID: 10795144
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR.
    J Hum Hypertens; 2007 Oct 18; 21(10):770-9. PubMed ID: 17597800
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.